A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

NCT05488353 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators